Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Best Biotech Stocks

Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).

Compare up to 10 stocks

Comparison Results

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Smart Score	Market Cap	P/E Ratio	Dividend Yield	Sector	Article	Follow
GILD Gilead Sciences	$106.89	2.73M	xxxxxxxxxxxxx	18 Buy 8 Hold 0 Sell Moderate Buy		$129.71B	273.89	2.96%	Healthcare
AMGN Amgen	$291.87	717.84K	xxxxxxxxxxxxx	11 Buy 7 Hold 1 Sell Moderate Buy		$156.51B	38.51	3.09%	Healthcare
VRTX Vertex Pharmaceuticals	$466.42	429.39K	xxxxxxxxxxxxx	15 Buy 12 Hold 1 Sell Moderate Buy		$117.87B	-208.47	―	Healthcare
BIIB Biogen	$135.74	638.49K	xxxxxxxxxxxxx	12 Buy 13 Hold 0 Sell Moderate Buy		$20.10B	12.28	―	Healthcare
ILMN Illumina	$102.36	1.42M	xxxxxxxxxxxxx	5 Buy 7 Hold 2 Sell Hold		$15.88B	-12.98	―	Healthcare
REGN Regeneron	$681.49	233.81K	xxxxxxxxxxxxx	16 Buy 3 Hold 1 Sell Strong Buy		$73.64B	17.59	0.00%	Healthcare
MRNA Moderna	$35.96	6.40M	xxxxxxxxxxxxx	2 Buy 11 Hold 4 Sell Hold		$12.70B	-3.85	―	Healthcare
IQV IQVIA Holdings	$195.98	1.02M	xxxxxxxxxxxxx	15 Buy 4 Hold 0 Sell Strong Buy		$34.06B	25.79	―	Healthcare
BNTX BioNTech SE	$119.50	264.78K	xxxxxxxxxxxxx	11 Buy 2 Hold 0 Sell Strong Buy		$28.49B	-58.43	―	Healthcare

Performance Comparison

GILD

Gilead Sciences

105.25

36.04

52.07%

AMGN

Amgen

292.80

17.68

6.43%

VRTX

Vertex Pharmaceuticals

462.11

41.47

9.86%

BIIB

Biogen

136.57

-82.64

-37.70%

ILMN

Illumina

101.09

-35.01

-25.72%

REGN

Regeneron

680.00

-266.87

-28.18%

MRNA

Moderna

35.75

-51.24

-58.90%

IQV

IQVIA Holdings

193.15

-41.61

-17.72%

BNTX

BioNTech SE

122.75

31.51

34.54%

Biotech Latest News

Arcus Biosciences price target lowered to $17 from $22 at BofA

Arcus Biosciences price target lowered to $17 from $22 at BofA

BofA lowered the firm’s price target on Arcus Biosciences (RCUS) to $17 from $22 and keeps a Neutral...

7h ago

Moderna price target lowered to $78 from $96 at UBS

Moderna price target lowered to $78 from $96 at UBS

UBS lowered the firm’s price target on Moderna (MRNA) to $78 from $96 and keeps a Buy rating...

7h ago

Delta flight crashes in Toronto, Southwest cuts corporate roles: Morning Buzz

Delta flight crashes in Toronto, Southwest cuts corporate roles: Morning Buzz

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists....

1d ago

Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright

Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Arcus Biosciences (RCUS) to $18 from $20 and keeps a...

1d ago

Early notable gainers among liquid option names on February 18th

Early notable gainers among liquid option names on February 18th

Notable gainers among liquid option names this morning include Super Micro (SMCI) $53.89 +5.98, Walgreen Boots (WBA) $10.64...

1d ago

Lyft downgraded, Snowflake upgraded: Wall Street’s top analyst calls

Lyft downgraded, Snowflake upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

1d ago

Stoke Therapeutics price target raised to $47 from $35 at H.C. Wainwright

Stoke Therapeutics price target raised to $47 from $35 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Stoke Therapeutics (STOK) to $47 from $35 and keeps a...

1d ago

Illumina price target lowered to $90 from $110 at BofA

Illumina price target lowered to $90 from $110 at BofA

BofA lowered the firm’s price target on Illumina (ILMN) to $90 from $110 and keeps an Underperform rating...

1d ago

Gilead announces FDA acceptance of lenacapavir NDA submissions

Gilead announces FDA acceptance of lenacapavir NDA submissions

Gilead (GILD) announced that the FDA has accepted its new drug application submissions for lenacapavir, the company’s twice-yearly...

1d ago

Biogen, Stoke Therapeutics announce zorevunersen commercialization agreement

Biogen, Stoke Therapeutics announce zorevunersen commercialization agreement

Biogen (BIIB) and Stoke Therapeutics (STOK) announced a collaboration for the development and commercialization of zorevunersen, a potential...

1d ago

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Moderna

Buy

Reiterated

2025-02-19

Gilead Sciences

Buy

Reiterated

2025-02-18

Biogen

Hold

Reiterated

2025-02-18

BioNTech SE

Buy

Reiterated

2025-02-18

IQVIA Holdings

Buy

Reiterated

2025-02-18

Illumina

Sell

Reiterated

2025-02-18

Amgen

Hold

Reiterated

2025-02-13

Vertex Pharmaceuticals

Buy

Reiterated

2025-02-12

Regeneron

Buy

Reiterated

2025-02-11

Moderna

Hold

Reiterated

2025-02-18

Most Recent Earnings of Biotech Stocks

Gilead Sciences

Feb 11, 2025

Dec 01, 2024

1.74 / 1.90

-1.32

Amgen

Feb 04, 2025

Dec 01, 2024

5.09 / 5.31

3.96

Vertex Pharmaceuticals

Feb 10, 2025

Dec 01, 2024

4.02 / 3.98

4.76

Biogen

Feb 12, 2025

Dec 01, 2024

3.33 / 3.44

3.67

Illumina

Feb 06, 2025

Dec 01, 2024

0.91 / 0.95

0.087

Regeneron

Feb 04, 2025

Dec 01, 2024

11.28 / 12.07

9.55

Moderna

Feb 14, 2025

Dec 01, 2024

-2.68 / -2.91

-3.07

IQVIA Holdings

Feb 06, 2025

Dec 01, 2024

3.11 / 3.12

2.54

BioNTech SE

Nov 04, 2024

Sep 01, 2024

-1.60 / 0.85

1.9

Biotech - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

Regeneron - Strong Buy, based on 20 analyst ratings, 16 Buy, 3 Hold, and 1 Sell.

IQVIA Holdings - Strong Buy, based on 19 analyst ratings, 15 Buy, 4 Hold, and 0 Sell.

BioNTech SE - Strong Buy, based on 13 analyst ratings, 11 Buy, 2 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $106.89, and its average 12-month price target is $108.05.

Amgen's stock price is currently $291.87, and its average 12-month price target is $330.63.

Vertex Pharmaceuticals's stock price is currently $466.42, and its average 12-month price target is $502.79.

Biogen's stock price is currently $135.74, and its average 12-month price target is $191.86.

Illumina's stock price is currently $102.36, and its average 12-month price target is $149.83.

Regeneron's stock price is currently $681.49, and its average 12-month price target is $958.60.

Moderna's stock price is currently $35.96, and its average 12-month price target is $45.14.

IQVIA Holdings's stock price is currently $195.98, and its average 12-month price target is $246.25.

BioNTech SE's stock price is currently $119.50, and its average 12-month price target is $142.84.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.79 which represents an annual dividend yield of 2.96%. Gilead Sciences's next Ex-dividend date is March 14, 2025 and its next payout date is March 28, 2025.

Amgen does not currently pay dividends.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron currently pays a dividend of $0.88 which represents an annual dividend yield of ―%. Regeneron's next Ex-dividend date is February 20, 2025 and its next payout date is March 20, 2025.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.